Wyeth (WYE) And Progenics Pharmaceuticals, Inc. (PGNX) Initiate Second Global Phase 3 Trial Of Intravenous Methylnaltrexone To Treat Post-operative Ileus
12/20/2006 3:21:14 PM
More...
|
Wyeth (WYE) Wins Philadelphia Phase II Diet Drug Cases
10/19/2005 5:13:15 PM
More...
|
Wyeth (WYE) Joins Nationwide Program To Assure Patient Access To Important Pharmaceutical Products
10/19/2005 5:13:14 PM
More...
|
Wyeth-Vaccines Researchers Honored By Pharmaceutical Industry
10/19/2005 5:13:07 PM
More...
|
Wyeth (WYE) To Present At The Smith Barney Citigroup Health Care Conference
10/19/2005 5:13:06 PM
More...
|
Wyeth (WYE) Release: National Institutes of Health (NIH) State-Of-The-Science Panel Supports Use Of Hormone Therapy For Treatment Of Moderate To Severe Menopausal Symptoms
10/19/2005 5:13:06 PM
More...
|
Wyeth (WYE) Comments On Earnings Guidance For 2005 First Quarter; Addresses Analyst Estimates
10/19/2005 5:13:05 PM
More...
|
Wyeth-Vaccines Researchers Honored By Pharmaceutical Industry
10/19/2005 5:13:05 PM
More...
|
Wyeth (WYE) Sets Webcast For Annual Meeting Of Stockholders
10/19/2005 5:13:02 PM
More...
|
Wyeth (WYE) Release: InductOs(TM) (rhBMP-2/ACS) Receives Additional European Commission Marketing Authorization
10/19/2005 5:13:02 PM
More...
|
|